Michael Fisher

It is now possible to modify dozens – if not hundreds – of genes in a cell simultaneously after researchers at ETH Zurich refined...

Rozlytrek (entrectinib) has been approved in the US for treating adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC). Roche confirmed that the FDA has...

Healthcare industry professionals around the globe believe that the UK will not leave the EU on the current agreement on 31 October, survey results...